Collectively, these data and the widespread expression of AR in primary and metastatic breast tumours, justify a careful examination of the therapeutic potential of androgens also in potentiating the effectiveness of anti-oestrogen adjuvant therapies. This evidence concerns the gene AR and breast neoplasm.